FDA inspection
Lexenpharm (Suzhou) Limited: FDA inspection ending Jan 16, 2024
FDA inspection 1227981 · Voluntary Action Indicated (VAI) · Suzhou
Key facts
| Inspection ID | 1227981 |
|---|---|
| Firm | Lexenpharm (Suzhou) Limited |
| FEI number | 3017676021 |
| Address | Suzhou Industrial Park, 218 Sangtian Street |
| City | Suzhou |
| Fiscal year | 2024 |
| Inspection end date | Jan 16, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data